FP7_logo
EU_flag
   
Publications

Partner 2a

Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis
S.H.E. Kaufmann, S. Baumann, A. Nasser Eddine International J. Tuberc. Lung Dis. 2006, 10, 1068-1079.

Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. 
J. Mattow, F. Siejak, K. Hagens, D. Becher, D. Albrecht, A. Krah, F. Schmidt, P.R. Jungblut, S.H.E. Kaufmann, U.E. Schaible Proteomics 2006, 6, 2485-2494.

Reliable amplification method for bacterial RNA.    
H. Rachman, J.S. Lee, J. Angermann, J. Kowall, S.H.E. Kaufmann J. Biotechnol. 2006, 126, 61-68.

Mycobacterium tuberculosis gene expression profiling within the context of protein networks.
H. Rachman, M. Strong, U.E. Schaible, J. Schuchhardt, K. Hagens, H. Mollenkopf, D. Eisenberg, S.H.E. Kaufmann Microbes. Infect. 2006, 8, 747-757.

 

 

Title: New Approaches to Target Tuberculosis


Acronym: NATT


Contract number: 222965


EC contribution: 2.994.478 €


Duration: 36 months


Starting date: 01/10/2008


Instrument:
Collaborative project